Benzodiazepine CGRP receptor antagonists

Details for Australian Patent Application No. 2004252150 (hide)

Owner Merck & Co., Inc.

Inventors Burgey, Christopher S.; Stump, Craig A.; Williams, Theresa M.

Agent Spruson & Ferguson

Pub. Number AU-B-2004252150

PCT Pub. Number WO2005/000807

Priority 60/482,674 26.06.03 US

Filing date 24 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 20 November 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000807 Priority application(s): WO2005/000807

20 November 2008 Application Accepted

  Published as AU-B-2004252150

19 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252151-Razor having a multi-position shaving head

2004252149-Rolled substrate products with highly registered printed images and embossment patterns